Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

ASTIC Autologous Stem Cell Transplantation for Crohn's Disease

This study has been terminated.
(For safety reasons the recruitment was halted prematurely. Patients on the trial continute to receive treatment and are being followed up as part the protocol.)
Sponsor:
Collaborator:
The Broad Foundation
Information provided by (Responsible Party):
European Group for Blood and Marrow Transplantation
ClinicalTrials.gov Identifier:
NCT00297193
First received: February 27, 2006
Last updated: August 29, 2013
Last verified: August 2013